Skip to Content

View Additional Section Content

CL-PTL-119- VITAL- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Vigilâ„¢ Engineered Autologous Tumor Cell Immunotherapy in Subjects with Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy

For more information on this trial, click the link below.

Principal Investigator(s)
Parviz Hanjani, M.D.

Clinical Trial Categories

  • Ovarian Cancer
Hanjani Institute for Gynecologic Oncology at 215-885-0220


  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory


Schedule a


Clinical Trials Details